Effects of Minimally Invasive Percutaneous and Trans-Spatium Intermuscular Short-Segment Pedicle Instrumentation on Thoracolumbar Mono-Segmental Vertebral Fractures Without Neurological Compromise.

S. H. Dong,H. N. Chen,J. W. Tian,T. Xia,L. Wang,Q. H. Zhao,C. Y. Liu
DOI: https://doi.org/10.1016/j.otsr.2012.12.020
IF: 2.425
2013-01-01
Orthopaedics & Traumatology Surgery & Research
Abstract:Objective: To compare the outcomes of minimally invasive percutaneous short-segment pedicle instrumentation (SSPI) with that of trans-spatium intermuscular SSPI on thoracolumbar monosegmental vertebral fracture without neurological compromise.Methods: A total of 39 patients with thoracolumbar mono-segmental vertebral fracture without neurological deficit receiving treatment between January 2009 and July 2011 were enrolled. Percutaneous SSPI was performed for 18 patients (the percutaneous group), and trans-spatium intermuscular SSPI was performed for 21 patients (the trans-spatium intermuscular group). Peroperative indices, intraoperative radiation exposure time, postoperative and follow-up lumbodorsal pain, function scores, and radiological data were compared.Results: The percutaneous group had significantly less intraoperative blood loss and less severe postoperative pains, but suffered significantly longer fluoroscopy time and higher hospitalization costs compared with the trans-spatium intermuscular group. No significant difference was observed in operating time. All patients were followed up for 17.3 +/- 9.2 months (ranging from 5 to 35 months). No significant differences were observed between the two groups in terms of postoperative relative vertebral height (RVH) and regional kyphotic angle (RKA), as well as last follow-up RVH, RKA, lumbodorsal pain, and Oswestry disability index.Conclusion: Percutaneous SSPI has the virtues of less intraoperative blood loss and less severe pains in the treatment of thoracolumbar mono-segmental vertebral fracture without neurological deficit. When compared with trans-spatium intermuscular SSPI, it results in longer intraoperative radiation exposure time and a higher surgery cost. To us, percutaneous SSPI has no advantage over trans-spatium intermuscular SSPI in therapeutic outcomes. (C) 2013 Elsevier Masson SAS. All rights reserved.
What problem does this paper attempt to address?